Seite 1 von 59 Asthma Leitlinie: Referenzen [www.evidence.de ...
Seite 1 von 59 Asthma Leitlinie: Referenzen [www.evidence.de ...
Seite 1 von 59 Asthma Leitlinie: Referenzen [www.evidence.de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Asthma</strong> <strong>Leitlinie</strong>: <strong>Referenzen</strong> [<strong>www</strong>.<strong>evi<strong>de</strong>nce</strong>.<strong>de</strong>] evi<strong>de</strong>nzbasierte <strong>Leitlinie</strong>n<br />
451.Powell, C. V., et al., Successful implementation of spacer treatment gui<strong>de</strong>line for acute asthma. Arch Dis<br />
Child, 2001. 84(2): p. 142-6.<br />
Evi<strong>de</strong>nzklasse: III<br />
Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=111<strong>59</strong>290<br />
452.Prahl, P., Petersen, N. T., and Hornsleth, A., Beta 2-agonists for the treatment of wheezy bronchitis? Ann<br />
Allergy, 1986. 57(6): p. 439-41.<br />
Evi<strong>de</strong>nzklasse: IIa<br />
Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3789471<br />
453.Price DB, et al., Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy<br />
(COMPACT) International Study Group. Randomised controlled trial of montelukast plus inhaled bu<strong>de</strong>soni<strong>de</strong><br />
versus double dose inhaled bu<strong>de</strong>soni<strong>de</strong> in adult patients with asthma. Thorax. 2003 Mar;58(3):211-6., 2003.<br />
Evi<strong>de</strong>nzklasse: Evi<strong>de</strong>nz Ib<br />
Link:<br />
454.Pri<strong>de</strong>, N. B., <strong>Asthma</strong>. Definition and clinical spectrum. Br Med Bull, 1992. 48(1): p. 1-9.<br />
Evi<strong>de</strong>nzklasse: III<br />
Link:<br />
455.Purello-D'Ambrosio, F., et al., Prevention of new sensitizations in monosensitized subjects submitted to<br />
specific immunotherapy or not. A retrospective study. Clin Exp Allergy, 2001. 31(8): p. 1295-302.<br />
Evi<strong>de</strong>nzklasse: III<br />
Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11529901<br />
456.Quackenboss, J. J., Lebowitz, M. D., and Krzyzanowski, M., The normal range of diurnal changes in peak<br />
expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis, 1991. 143(2): p.<br />
323-30.<br />
Evi<strong>de</strong>nzklasse: III<br />
Link:<br />
457.Rabe, K. F., et al., Comparison of the effects of salmeterol and formoterol on airway tone and<br />
responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis, 1993. 147(6 Pt 1): p. 1436-41.<br />
Evi<strong>de</strong>nzklasse: Ib<br />
Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8503554<br />
458.Ram, F. S., Robinson, S. M., and Black, P. N., Physical training for asthma. Cochrane Database Syst<br />
Rev, 2000. 2.<br />
Evi<strong>de</strong>nzklasse: Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/htbin-post/Entrez/query?<br />
db=m&form=6&dopt=r&uid=10796<strong>59</strong>9<br />
4<strong>59</strong>.Ram, F. S., et al., Systematic review of clinical effectiveness of pressurised metered dose inhalers versus<br />
other hand held inhaler <strong>de</strong>vices for <strong>de</strong>livering beta (2 )agonists bronchodilators in asthma. Bmj, 2001. 323<br />
(7318): p. 901-5.<br />
Evi<strong>de</strong>nzklasse: Ia<br />
Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11668134<br />
460.Ramage, L., et al., Reduced protection against exercise induced bronchoconstriction after chronic dosing<br />
with salmeterol. Respir Med, 1994. 88(5): p. 363-8.<br />
Evi<strong>de</strong>nzklasse: Ib<br />
Link:<br />
461.Rasmussen, F., et al., Impact of airway lability, atopy, and tobacco smoking on the <strong>de</strong>velopment of<br />
asthma-like symptoms in asymptomatic teenagers. Chest, 2000. 117(5): p. 1330-5.<br />
Evi<strong>de</strong>nzklasse: III<br />
Link: http://<strong>www</strong>.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10807819<br />
http://<strong>www</strong>.<strong>evi<strong>de</strong>nce</strong>.<strong>de</strong>/<strong>Leitlinie</strong>n/leitlinien-intern/<strong>Asthma</strong>_Start/<strong>Asthma</strong>_<strong>Referenzen</strong>...<br />
<strong>Seite</strong> 41 <strong>von</strong> <strong>59</strong><br />
09.07.2005